...

ECZACIBAŞI
PHARMACEUTICAL AND
INDUSTRIAL INVESTMENT CO.

FINANCIAL INFORMATION

2024/09

2023/09

Revenue

6.331.499

6.762.969

Gross Profit

2.518.918

3.020.501

Operating Profit

914.663

1.379.212

Depreciation and Amortisation

487.959

539.329

EBITDA

1.402.622

1.918.541

Net Income

921.003

787.618

2024/09

2023/12

Total Assets

56.982.358

59.095.318

Total Shareholder's Equity

47.393.424

47.343.197

Total Current Assets

6.208.415

7.448.065

Total Current Liabilities

3.702.760

4.639.171

Current Ratio

1,68

1,61

Liquidity Ratio

1,22

1,14

Total Liabilities / Total Assets

0,17

0,2

Total Shareholders' Equity / Total Assets

0,83

0,8

Total Shareholders' Equity / Total Liabilities

4,94

4,03

Net Income / Total Shareholders' Equity

0,02

0,08

Net Income / Total Assets

0,02

0,06

Net Income / Revenue

0,15

0,42

Year

Date

Free Issue (%)

Right Issue (%)

Before (TRY)

Now (TRY)

1992

11.11.1992

70

70

150,000

360,000

1994

16.06.1994

115

20

360,000

846,000

1995

13.09.1995

80

-

846,000

1,522,800

1996

25.07.1996

100

-

1,522,800

3,045,600

1999

26.03.1999

300

-

3,045,600

12,182,400

2003

14.05.2003

200

-

12,182,400

36,547,400

2004

13.01.2004

400

-

36,547,200

182,736,000

2008

30.07.2008

200

-

182,736,000

548,208,000

2016

03.11.2016

25

-

137,052,000

685,260,000

Yearly Profit Distribution

2003

28.06.2004

15

13,5

15

-

2004

31.05.2005

7

6,3

7

-

2005

-

-

-

-

-

2006

-

-

-

-

-

2007

26.05.2008

15

12,75

15

-

2008

26.05.2009

11,3

9,605

11,3

2009

25.05.2010

7

5,95

7

2010

24.05.2011

7

5,95

7

2011

19.06.2012

10

8,5

10

-

2012

28.05.2013

10

8,5

10

-

2013

06.05.2014

9,6

8,16

9,6

-

2014

05.05.2015

8

6,8

8

-

2015

10.05.2016

40

34

40

-

2016

08.05.2017

50

42,5

50

-

2017

22.05.2018

20

17

20

-

2018

20.05.2019

30

25,5

30

-

2019

14.04.2020

7,3

6,205

7,3

-

2020

26.04.2021

22

18,7

22

-

2021

24.05.2022

29,2

26,28

29,2

-

2022

25.04.2023

41

36,9

41

-

...

ABOUT US

...

CORPORATE MANAGEMENT

...

ANNOUNCEMENTS AND
PRESENTATIONS

...

GENERAL ASSEMBLY